Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates
about
Distinct functions of opioid-related peptides and gastrin-releasing peptide in regulating itch and pain in the spinal cord of primates.Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112.Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.Neuraxial opioid-induced itch and its pharmacological antagonismRoles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates.Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritusThe therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability.Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development.Targeted treatment of pruritus: a look into the futureInvestigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice.Nalfurafine suppresses pruritogen- and touch-evoked scratching behavior in models of acute and chronic itch in mice.Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice.Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats.Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch.The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice.
P2860
Q30655924-994FBACD-EA1F-4D57-B601-70DF380BF7DAQ33817107-D7CB1BF9-99FD-40E9-9F42-539E57216930Q34294075-D8FE070B-08B7-4FA8-8B76-57F7725B34A9Q35659494-A080DE85-3ECF-4DC9-8D50-817B11C14DE8Q36296864-1ACA4FB3-FB5B-4B0F-A806-26D6636E718EQ36539104-8B646532-8F63-425B-B2EE-42BAC0F5FB0CQ36638633-B99A4019-0761-412E-AF75-5D4F9EF3726FQ37638416-D3BC8D3B-09E4-4619-B1D7-05C1D7153723Q37800506-0BFAFF4A-D9EB-446C-A24C-70825A5756DAQ37827172-60171741-B4A6-4E5C-A7FD-712F728D9A3CQ38901893-34A498F6-806F-4BF6-AB97-416290FE133DQ41328175-94383662-CE84-4A89-85BE-BB46B1FB0359Q42540243-9E3CDE11-D5E5-45B2-97C6-72860A28077DQ44346108-B350706A-8D99-4D41-A11F-CD84B370E9E5Q44350139-E7DC49D5-C5B5-4399-B5B2-D1B1EC491100Q47977698-9ADD4B3B-BE9E-418B-9CCB-175590DFFA14
P2860
Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Effects of atypical kappa-opio ...... itch and analgesia in primates
@ast
Effects of atypical kappa-opio ...... itch and analgesia in primates
@en
Effects of atypical kappa-opio ...... itch and analgesia in primates
@nl
type
label
Effects of atypical kappa-opio ...... itch and analgesia in primates
@ast
Effects of atypical kappa-opio ...... itch and analgesia in primates
@en
Effects of atypical kappa-opio ...... itch and analgesia in primates
@nl
prefLabel
Effects of atypical kappa-opio ...... itch and analgesia in primates
@ast
Effects of atypical kappa-opio ...... itch and analgesia in primates
@en
Effects of atypical kappa-opio ...... itch and analgesia in primates
@nl
P2860
P356
P1476
Effects of atypical kappa-opio ...... itch and analgesia in primates
@en
P2860
P304
P356
10.1124/JPET.108.143925
P407
P577
2009-01-01T00:00:00Z